2024-520196-27-00RecruitingPhase 1
A phase Ib, open-label, ascending dose study to assess safety, tolerability and pharmacokinetics of PIT565 in participants with rheumatoid arthritis (RA)
Source: EU CTIS (euclinicaltrials.eu) · Last updated 1 Apr 2026
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- First submitted
- 27 Mar 2025
- Start date
- 1 Oct 2025
- Lead sponsor
- Novartis Pharma AG
- Diseases
- Rheumatoid arthritis
- EU CT number
- 2024-520196-27-00
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 40
- 13 sites in 7 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (13)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Multispecialty hospital for active treatment Sveta Sofia EOOD | Sofiya | Bulgaria | Suspended |
| Universitaetsklinikum Jena KöR | Jena | Germany | Suspended |
| Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR | Mainz | Germany | Suspended |
| Hospital Universitari Vall d'Hebron | Barcelona | Spain | Suspended |
| Complexo Hospitalario Universitario De Santiago | Santiago de Compostela | Spain | Suspended |
| Centre Hospitalier Régional et Universitaire de Brest | Brest | France | Not yet recruiting |
| Bicetre Hospital | Le Kremlin Bicetre Cedex | France | Not yet recruiting |
| Assistance Publique Hopitaux de Paris | Paris | France | Not yet recruiting |
| Betegapolo Irgalmasrend Budai Irgalmasrendi Korhaz | Budapest II | Hungary | Suspended |
| University of Szeged | Szeged | Hungary | Suspended |
| Centre for Human Drug Research | Leiden | Netherlands | Not yet recruiting |
| Arensia Clinics S.R.L. | Bucharest | Romania | Suspended |
| Spitalul Clinic Judetean De Urgenta Cluj | Cluj-Napoca | Romania | Suspended |
This page is information, not medical advice. Discuss any trial with your doctor.